A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Stryker Announces They Have Released their Emergency Relief Bed™: A Limited-Release Medical Bed to Support Sritical Needs During a Pandemic

Stryker has developed a low-cost, limited-release emergency response bed, Emergency Relief Bed™,  to quickly aid healthcare providers with efficient care during the COVID-19 pandemic.

Brad Saar, president of Stryker’s Medical division notes, “People are at the heart of what we do, and COVID-19 hasn’t changed that. It has amplified our mission of making healthcare better. We’re focused on meeting the supply needs of our customers so they can focus on taking care of patients right now. He concluded, “That’s why we raced to develop our Emergency Relief Bed, which will help emergency responders and caregivers move and position patients efficiently during this critical time.”

Stryker anticipates producing 10,000 beds a week to meet increased needs.

Stryker’s Emergency Relief Bed is a low-cost, readily available solution intended to serve those on the front lines – ranging from hospital emergency departments to triage and pop-up areas of care. It includes a six-inch-thick foam surface.

The Emergency Relief Bed features a 30-degree head of bed angle to accommodate patients in respiratory distress, including ventilated patients. It also features low height and an attached IV pole.

The bed is intended for use in the COVID-19 pandemic to support increased patient numbers in healthcare facilities. Stryker is actively pursuing making the bed available in select markets around the world.

SourceStryker
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy